Prescription Drugs
Filters
Kadcyla 赫赛莱 Ado-trastuzumab Emtansine (T-DM1) 100/160mg | Roche China Originator | GLT
NMPA-approved Roche Kadcyla 赫赛莱 ado-trastuzumab emtansine (T-DM1) 100mg & 160mg vials, China originator HER2-targeted ADC.
Kadcyla Ado-trastuzumab Emtansine (T-DM1) 100/160mg | Roche EU Originator | GLT
EMA-approved Roche Kadcyla ado-trastuzumab emtansine (T-DM1) 100mg & 160mg vials, EU originator HER2-targeted ADC.
Votrient (Pazopanib) 200mg*30 | Novartis China | GLT
China-Mainland Votrient 200mg — Novartis originator pazopanib, NMPA-approved & nationally reimbursed
Saiweike (Pazopanib) 200mg*30 | Chia Tai Tianqing China Generic | GLT
Nanjing Chia Tai Tianqing — pazopanib 200mg generic for renal cell carcinoma & soft tissue...
Dipaite (Pazopanib) 200mg*30 | Acebright China Generic | GLT
Shanghai Acebright — pazopanib 200mg generic for renal cell carcinoma & soft tissue sarcoma
Wanxiwei (Pazopanib) 200mg*30 | Loncom China Generic | GLT
Shandong Loncom — pazopanib 200mg generic for renal cell carcinoma & soft tissue sarcoma
Pivikto (Alpelisib) 150mg 28 Tablets | Novartis India Original | GLT
Pivikto — Novartis India's original alpelisib brand, the most affordable genuine original for PIK3CA-mutated breast...
Piqray (Alpelisib) 150mg 56 Tablets | Novartis Hong Kong Original | GLT
Piqray Hong Kong original — 56 tablets = one 28-day treatment month, Novartis, approved in...
Piqray (Alpelisib) 150mg/200mg Tablets | Novartis Germany Original | GLT
Piqray — the Novartis original PI3Kα inhibitor for PIK3CA-mutated HR+/HER2- breast cancer, German original cartons
DOVBLERON 达伯乐 (Taletrectinib) 0.2g Capsules | ROS1 Inhibitor | GLT
Innovent-marketed taletrectinib (same molecule as Ibtrozi) for ROS1-positive NSCLC
Pembrolizumab (Keytruda) 100mg/4mL | China-Sourced | GLT
PD-1 inhibitor for multiple cancers — China-sourced, NMPA-approved Keytruda at competitive global pricing
Sort
- Recommended
- Price: Low to High
- Price: High to Low
- Newest
- Best Selling